Effect of High-Flux versus Low-Flux Dialysis on the Rate of Bacteremia in Hemodialysis Patients: A Single Center Study by Dahouk, Ali et al.
 Journal of Renal and Hepatic Disorders 2021;5(2): 1–5 1
Journal of  Renal and Hepatic Disorders
ORIGINAL ARTICLE
Effect of High-Flux versus Low-Flux Dialysis on the Rate of  
Bacteremia in Hemodialysis Patients: A Single Center Study
Ali Dahouk1, Loubna Sinno2, Housam Rabah1
1Internal Medicine Department, Makassed General Hospital, Beirut, Lebanon; 2Research Unit, Makassed General Hospital, Beirut, Lebanon.
Abstract 
Bacteremia in dialysis patients is a major risk factor of mortality. The aim of this study was to assess the effectiveness of dialysis with high-flux 
versus low-flux dialyzer regarding risk of bacteremia in dialysis patients. This was a retrospective cohort study that included dialysis patients 
who underwent dialysis therapy at old dialysis center where old low-flux dialyzers were used and the new dialysis center where high-flux dialyzers 
were used. The rate of positive culture was more in high-flux group (37.0%) compared to low-flux group (24.5%), although the difference was 
not statistically significant (P = 0.13). The vascular access was mostly permanent catheter in high-flux group compared to low-flux group (48.9% 
vs. 28.6%, respectively; P = 0.06), while arteriovenous (AV) fistula was more prominent in low-flux group compared to high-flux group (65.3% 
vs. 47.8%, respectively; P = 0.06). This was reflected in the type of bacteria, which was mostly from Gram-positive family (Staphylococcus). The 
results showed higher risk of bacteremia in high-flux group as compared to low-flux group; however, permanent catheters were more prominent 
in high-flux group.
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Introduction 
Since the beginning of dialysis, there has been a significant 
improvement in the modalities and the machines and filters 
used due to more understanding and improvement in the 
principles of dialysis. This has brought down the mortality 
rates of patients on dialysis (1). In spite of the advances made 
in the modalities of dialysis, bacteremia has remained as one 
of the most common complications in dialysis patients (2).
The risk of bacteremia in dialysis differs depending on dif-
ferent factors. It mainly depends on the presence or absence 
of dialysis lines such as non-tunneled catheter, permanent 
catheter, and arteriovenous (AV) graft (2). Until recently, the 
dialyzers used were considered to have small pores that did 
not allow the passage of bacteria into blood from dialysate. 
The average pore size of a dialyzer varies according to flux, 
ranging from 1.5 nm in low-flux to 5 nm in high-flux dia-
lyzer (3, 4), while the bacterial size is rarely less than 0.1 µm 
and only fragments of bacteria have small sizes of 5–10 nm 
in diameter (5). Lately, there has been an increase in the use 
of high-flux dialyzers because of the increased pore size and 
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hence the increased clearance of metabolic waste products 
of middle-size molecules such as beta 2 microglobulin that 
are associated with the pathogenesis of certain diseases in 
patients on dialysis (6). 
However, in spite of the discrepancy between the pore size 
of high-flux dialyzer and the bacterial diameter, there are 
concerns for increasing the flux of dialyzers, since it could 
raise the risk of exposure to cytokine-inducing bacterial sub-
stances in dialysate in this population of patients (7). The 
relation between pore size of membrane and permeability of 
bacterial pyrogens is still contentious (7, 8).
In light of the above discussion, the aim of this study was 
to assess the effectiveness of dialysis with high-flux versus 
low-flux dialyzers in terms of risk of bacteremia in patients 
undergoing dialysis.
Methods
This was a retrospective cohort study comprising hemodialy-
sis patients who were on dialysis at Makassed General Hos-
pital in Beirut between July 2018 and June 2020. Following 
the approval of the Institutional Review Board, data were 
collected during the stated period because the dialysis cen-
ter at Makassed General Hospital was renovated. The new 
center was opened in July 2019, where new dialysis machines 
(Fresenius 5004) were installed with the introduction of 
high-flux dialyzers. Previously, at the old division, machines 
were used with low-flux dialyzers. Hence, July 2019 was con-
sidered as a washout period to separate the use of high-flux 
from low-flux dialyzers. 
Inclusion criteria were all patients who underwent dialysis 
in the outpatient dialysis center between July 2018 and June 
2020 (one year before the start of new dialysis center where 
low-flux dialyzers were used and one year after the opening 
of new dialysis center where high-flux dialyzers where used). 
Only blood culture values (no other cultures such as wound 
or urine) were recorded. Exclusion criteria for the study 
included patients who had dialysis outside this time frame, 
those who did not have blood cultures collected, and hospital 
inpatients (since dialysis of inpatients was done on low-flux 
dialyzer machines compared to high-flux dialyzer machines 
in the new outpatient setting).
Data collected included demographic characteristics, his-
tory of bacteremia, type of vascular access in addition to 
blood culture results and the types of bacteria.
Statistical analysis
The Statistical Package for Social Sciences (SPSS, version 24) 
was used for data analysis. Categorical variables were pre-
sented as number and percentage values. Continuous vari-
ables were presented as mean value and standard deviation. 
Bivariate analysis was conducted using the Chi square test 
for comparing categorical variables. Continuous variables 
were compared using Student’s t-test. P < 0.05 indicated sta-
tistical significance.
Results
A total of 358 outpatient dialysis patients were enrolled at 
our center during the study period. Of these, 141 patients 
had blood culture recorded and hence eligible to be included 
in the study. Of these 141 patients, 49 were in low-flux group 
and 92 in high-flux group. Regarding the demographics of 
patients, age was similar in both the groups (72.06±14.08 
years in low-flux and 71.83±11.63 years in high-flux group). 
Around 63% of patients in low-flux group were males com-
pared to 53.3% in high-flux group. Diabetes mellitus (DM) 
was prevalent in both the groups. High-flux patients had dou-
ble the rate of malignancy at the time of the study, although 
the difference was not statistically significant (13% vs. 6.1%; 
P = 0.20). Likewise, high-flux patients had more episodes 
of previous bacteremia at the time of the study (53.3% vs. 
44.9%; P = 0.34). However, the rate of blood transfusion was 
comparable between both the groups (52.2% in high-flux vs. 
53.1% in low-flux group; P = 0.92) (Table 1). 
Regarding the primary outcome of this study examining 
the risk of bacteremia in high-flux versus low-flux patients, 
it was apparent that patients on high-flux dialysis had higher 
risk of bacteremia than those on low-flux dialysis, although 
the difference was not statistically significant (37% vs. 24.5%; 
P = 0.13) (Table 2). 
Regarding vascular access, it was found that AV fistula was 
more prominent in low-flux compared to high-flux patients 
(65.3% vs. 47.8%; P = 0.06). On the other hand, permanent 
catheter usage was more in high-flux compared to low-flux 
patients (48.9% vs. 28.6%; P = 0.06) (Table 2).
Regarding the type of  pathogen that caused bacteremia 
in blood cultures, coagulase negative staphylococci was 
the most prominent pathogen found in high-flux group 
(44.1%), which could have been related to catheter place-
ment, followed by equal percentage (8.8%) of  Escherichia 
coli, Staphylococcus aureus, and Staphylococcus saprophyt-
icus. In the low-flux group, Enterobacter species were the 
most common causal pathogen (41.7%), followed by Staph-
ylococcus aureus and Staphylococcus saprophyticus (16.7% 
each) (Table 2).
Discussion
The present study showed that the rate of bacteremia was 
slightly more in high-flux patients compared to low-flux 
patients, although the difference was not statistically signif-
icant. Moreover, AV fistula was more prominent in low-flux 
patients whereas usage of permanent catheter was more in 
high-flux patients.
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Table 1: Patients’ demographic characteristics.
Low-flux patients (n = 49) High-flux patients (n = 92) P-value
Age Years 72.06 ± 14.08 71.83 ± 11.63 0.92
Gender Male 31 (63.3%) 49 (53.3%) 0.25
Female 18 (36.7%) 43 (46.7%)
Diabetes mellitus 33 (67.3%) 66 (71.7%) 0.59
Malignancy 3 (6.1%) 12 (13.0%) 0.20
Duration of dialysis Years 4.45 ± 1.26 4.55 ± 1.88 0.69
History of blood transfusion 26 (53.1%) 48 (52.2%) 0.92
History of bacteremia 22 (44.9%) 49 (53.3%) 0.34
Number of previous bacteremia episodes 1.73 ± 0.99 1.73 ± 1.11 0.98
Table 2: Primary outcome of the risk of bacteremia in high- and low-flux patients.
Low-flux patients (n = 49) High-flux patients (n = 92) P-value
Vascular 
access
AV fistula 32 (65.3%) 44 (47.8%) 0.06
Permanent catheter 14 (28.6%) 45 (48.9%)
Non-tunneled catheter 3 (6.1%) 3 (3.3%)
Positive 
culture
No 37 (75.5%) 58 (63.0%) 0.13
Yes 12 (24.5%) 34 (37.0%)
Bacteria type Coagulase-negative Staphylococci  2 (16.7%) 15 (44.1%) 0.06
Enterobacter species 5 (41.7%) 1 (2.9%)
E coli 0 (0.0%) 3 (8.8%)
Klebsiella pneumonia 1 (8.3%) 1 (2.9%)
Staphylococcus aureus 2 (16.7%) 3 (8.8%)
Staphylococcus MRSA 0 (0.0%) 2 (5.9%)
Staphylococcus saprophyticus  2 (16.7%) 3 (8.8%)
Viridans streptococci group 0 (0.0%) 1 (2.9%)
Pseudomonas aeruginosa  0 (0.0%) 1 (2.9%)
Pseudomonas stutzeri  0 (0.0%) 1 (2.9%)
Chryseobacterium 0 (0.0%) 1 (2.9%)
Bacillus species  0 (0.0%) 1 (2.9%)
Alcaligenes species 0 (0.0%) 1 (2.9%)
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Several previous studies had controversial results regard-
ing the effect of high-flux versus low-flux dialyzers on the 
translocation of bacterial products (7, 8). Gordon et al. con-
ducted a study assessing the incidence of pyrogenic reactions 
when shifting from conventional dialysis to high-efficiency 
high-flux dialysis, taking data from three different dialysis 
centers with a total of 27,087 hemodialysis patients. How-
ever, there was no significant difference in the pyrogenic reac-
tion rates (9). 
This shows discrepancy in the effect of dialyzer flux on 
different outcomes. However, few studies have focused on 
the risk of infection per se when comparing high- and low-
flux dialyzers (10). Instead, the main comparisons included 
patients’ overall mortality, hospital admission, and quality 
of life (11–14). In this regard, Kantartzi et al. compared 
the quality of life of hemodialysis patients using low- and 
high-flux dialyzers, and concluded that the quality of life of 
dialysis patients was significantly better with high-flux dia-
lyzers compared to when they used low-flux dialyzers (12). 
Results of the Hemodialysis Study (HEMO) indicated that 
infection-related death or hospitalization did not differ in 
patients randomized to high- or low-flux membranes (13). 
Another study conducted by Kavyannejad et al. pointed no 
significant differences in the incidence and severity of com-
plications (variations in blood pressure, nausea, vomiting, 
itching, headache, and fever and chills) in patients during 
hemodialysis with low- or high-flux dialyzers (14). 
In the present study, when comparing the demographic 
characteristics of patients, age was comparable in both 
groups (mean age of around 72 years). Regarding comor-
bidities, diabetes mellitus was comparable in both groups 
(67.3% low flux vs. 71.7% high flux). Malignancy was more 
in high-flux group than in low-flux group (6.1% vs. 13%, 
respectively), while history of blood transfusion was compa-
rable in both the groups (53.1% vs. 52.2%).
Regarding the modality of dialysis, it was found that most 
of patients who underwent high-flux dialysis had permanent 
catheter access (48.9 % vs. 28.6%; P = 0.06), while the major-
ity of patients who underwent low-flux dialysis had AV fis-
tula (65.3% vs. 47.8%). 
Although it was apparent from the above results that rate 
of bacteremia was slightly more in high-flux group, there 
are several factors that might affect the results. First, age 
was similar in both groups, so it could not play a key role in 
affecting the outcomes of this study. Also, both groups were 
comparable for diabetes mellitus. However, the risk of malig-
nancy in high-flux group was double than in low-flux group. 
Neither the type of malignancy was reported at the time of 
the study (solid vs. hematologic), nor the time of diagno-
sis of tumors, whether patients were on chemotherapy, and 
whether they were neutropenic at the time of the study.
Second, it is a known fact that patients with end-stage 
renal disease have erythropoietin deficiency as well as a state 
of iron resistance and relative iron deficiency, and hence need 
blood transfusions occasionally (15). However, there was 
no discrepancy in the rate of blood transfusion in low- and 
high-flux dialysis patients (53.1% vs. 52.2%, respectively). 
Maybe, the most important factor is the mechanism of 
dialysis used in patients regarding vascular access (AV fistula 
vs. permanent or non-tunneled catheter). Permanent and 
non-tunneled catheters are foreign bodies and despite that 
the permanent catheter caries lower risk of bacteremia and 
is more sustainable as an access for dialysis due to its qual-
ity (tunneled catheter under the skin with subsequent fibrous 
sealing of the skin over the catheter that carries lower risk 
of bacteremia) (16). Nonetheless, such access carries greater 
risk of bacteremia than AV fistula (lower risk due to absence 
of line insertion into central venous system and absence of 
foreign bodies) (16). This was a major confounding factor 
in this study, since AV fistula was more prominent in low-
flux than high-flux dialysis (65.3% vs. 47.8%, respectively) as 
compared to tunneled catheters, which were more prominent 
in high-flux group (28.6% vs. 48.9%).
A limitation of the present study was that it included a sin-
gle center with small sample size. Yet, to our knowledge, it is 
the first study in Lebanon that exclusively assessed the rate 
of bacteremia in dialysis patients of outpatient department.
Conclusion
Results of the study showed that there was an increase in risk 
of bacteremia when shifting from low- to high-flux dialysis; 
however, the difference was not statistical significant. The 
prominence of permanent catheters as access for dialysis 
in high-flux group could be a confounding factor. Support-
ing this idea was the presence of Staphylococcal bacteremia 
(Gram-positive) as a causal bacterial agent of blood bactere-
mia in this group. A direct causal relationship between high-
flux dialysis and increased risk of bacteremia could not be 
established partly due to the presence of confounding factors.
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